Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Vladimir Zah, Rowe B Brookfield, Martina Imro, Simona Tatovic, Jovana Pelivanovic & Djurdja Vukicevic. (2019) Healthcare Costs And Resource Utilization In Chronic Pain Patients Treated With Extended-Release Formulations Of Tapentadol, Oxycodone, Or Morphine Stratified By Type Of Pain: A Retrospective Claims Analysis, 2012–2016. Journal of Pain Research 12, pages 3037-3048.
Read now
Read now
Tiffani D. Eisenhauer, Mike Matchett, Ralph Heasley, Terri Morton, Krishna Devarakonda, Michael Giuliani, Jim L. Young & Thomas Barrett. (2016) Evaluation of the tamper-resistant properties of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets. Drug Development and Industrial Pharmacy 42:1, pages 157-165.
Read now
Read now
Charles E. Argoff & Ernest A. Kopecky. (2014) Patients with chronic pain and dysphagia (CPD): unmet medical needs and pharmacologic treatment options. Current Medical Research and Opinion 30:12, pages 2543-2559.
Read now
Read now
C. Richard Chapman & David H. Bradshaw. (2013) Only Modest Long-Term Opioid Dose Escalation Occurs Over Time in Chronic Nonmalignant Pain Management. Journal of Pain & Palliative Care Pharmacotherapy 27:4, pages 370-377.
Read now
Read now
Articles from other publishers (18)
Ankita Mehta & Bhoomika M. Patel. (2023) Long-acting opioids and cardiovascular diseases: Help or hindrance!. Vascular Pharmacology 149, pages 107144.
Crossref
Crossref
Stephen E Nadeau & Richard A Lawhern. (2022) Management of chronic non-cancer pain: a framework. Pain Management 12:6, pages 751-777.
Crossref
Crossref
Andrea D. Furlan & Laura Murphy. 2022. Clinical Pain Management. Clinical Pain Management
188
197
.
Yasin Karamzadeh, Afshin Ansari Asl & Sohrab Rahmani. (2020) PCL microsphere/PEG‐based composite hydrogels for sustained release of methadone hydrochloride. Journal of Applied Polymer Science 137:33, pages 48967.
Crossref
Crossref
Luigi Cardia, Gioacchino Calapai, Domenico Quattrone, Cristina Mondello, Vincenzo Arcoraci, Fabrizio Calapai, Carmen Mannucci & Epifanio Mondello. (2018) Preclinical and Clinical Pharmacology of Hydrocodone for Chronic Pain: A Mini Review. Frontiers in Pharmacology 9.
Crossref
Crossref
Frieder Keller & Alexander Hann. (2018) Clinical Pharmacodynamics. Clinical Journal of the American Society of Nephrology 13:9, pages 1413-1420.
Crossref
Crossref
Joseph Pergolizzi, Maribeth Kowalski & Ellie He. (2018) Effectiveness and Safety of Once-Daily Extended-Release Hydrocodone in Individuals Previously Receiving Immediate-Release Oxycodone for Chronic Pain. Pain Medicine 19:5, pages 967-977.
Crossref
Crossref
Alexander M. Ponizovsky, Eli Marom, Abraham Weizman & Eyal Schwartzberg. (2018) Changes in consumption of opioid analgesics in Israel 2009 to 2016: An update focusing on oxycodone and fentanyl formulations. Pharmacoepidemiology and Drug Safety 27:5, pages 535-540.
Crossref
Crossref
Ernest A. Kopecky, Ben Vaughn, Scott Lagasse & Melinda O’Connor. (2017) Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial. Drugs & Aging 34:8, pages 603-613.
Crossref
Crossref
Nancy Verónica Alva Arroyo, José Manuel Athié García, Enrique Monares Zepeda & Diego Jaime Villalón. (2017) Evaluación del dolor con variaciones del videopupilómetro, usando analgesia con tapentadol en Terapia Intensiva Adultos. Acta Médica Grupo Ángeles 15:3, pages 175-180.
Crossref
Crossref
Ryan Mirchel, John R. Zuniga & Gary F. Bouloux. 2017. Complications of Temporomandibular Joint Surgery. Complications of Temporomandibular Joint Surgery
81
98
.
Nalini Vadivelu, Erika Schermer, Gopal Kodumudi & Jack M. Berger. (2016) The Clinical Applications of Extended-Release Abuse-Deterrent Opioids. CNS Drugs 30:7, pages 637-646.
Crossref
Crossref
Rami Ben-Joseph, Jill A. Bell, Diana Brixner, Anuraag Kansal, Clark Paramore, Abhishek Chitnis, Pamela Holly & Douglas S. Burgoyne. (2016) Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone. Journal of Managed Care & Specialty Pharmacy 22:4, pages 358-366.
Crossref
Crossref
Ram P. Kapil, Alessandra Cipriano, Warren Wen, Shau Yu Lynch, Ellie He, Salvatore V. Colucci & Stephen C. Harris. (2016) Pharmacokinetic Profile and Sustained 24-hour Analgesia of a Once-daily Hydrocodone Bitartrate Extended-release Tablet with Abuse-deterrent Properties. Clinical Therapeutics 38:2, pages 302-314.
Crossref
Crossref
Charlotte Martin, Edith Oyen, Jeroen Mangelschots, Mathieu Bibian, Tanila Ben Haddou, Jessica Andrade, James Gardiner, Bruno Van Mele, Annemieke Madder, Richard Hoogenboom, Mariana Spetea & Steven Ballet. (2016) Injectable peptide hydrogels for controlled-release of opioids. MedChemComm 7:3, pages 542-549.
Crossref
Crossref
Kuan Gandelman, Michael Lamson, Joanne Salageanu, Candace Bramson, Kyle Matschke & Bimal Malhotra. (2015) Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone. Clinical Pharmacology in Drug Development 4:5, pages 370-376.
Crossref
Crossref
Jessica M. Irvine, Sara E. Hallvik, Christi Hildebran, Miguel Marino, Todd Beran & Richard A. Deyo. (2014) Who Uses a Prescription Drug Monitoring Program and How? Insights From a Statewide Survey of Oregon Clinicians. The Journal of Pain 15:7, pages 747-755.
Crossref
Crossref
Esther Papaseit, Clara Pérez-Mañá, Marta Torrens & Magí Farré. (2013) Reacciones adversas de medicamentos relacionadas con el abuso y formas farmacéuticas disuasorias. Medicina Clínica 141:10, pages 454-458.
Crossref
Crossref